New Hope for Damaged Hearts
Posted by SR in News, tags: cardiovascular, kinase, regenerative medicine
A number of organs, including the heart, have limited regenerative powers, but US scientists have now shown that fully differentiated cardiac muscle cells can be induced to proliferate and regenerate. Writing in the journal Cell, they show that the growth factor neuregulin 1, which plays a role in early development of the heart and nervous system, induces mononucleated, but not binucleated, cardiomyocytes to divide in vitro by acting on the receptor tyrosine kinase, ErbB4. In mice, genetic inactivation of ErbB4 was shown to reduce cardiomyocyte proliferation, whereas increasing ErbB4 expression enhanced proliferation. Following heart attack in adult mice, daily intraperitoneal injection of neuregulin 1 for 12 weeks led to regeneration of the heart muscle and improved function. Unlike the control mice, the treated animals showed reduced signs of heart failure such as left-ventricular dilation and cardiac hypertrophy. If the neuregulin/ErbB4 signalling pathway plays the same role in human heart muscle, stimulating proliferation of differentiated cardiomyocytes by activation of this pathway may provide an alternative to stem cell therapy to regenerate damaged heart muscle in patients with heart failure or children with congenital heart defects. Since ErbB receptor tyrosine kinases and neuregulins have oncogenic potential and may cause proliferation of other tissues, a full safety assessment would be needed before any clinical studies.
Neuregulin 1 has previously been associated with susceptibility to schizophrenia and has also been shown to protect neurones following stroke.
Related posts:
- Mending a Broken Heart Heart disease is a leading cause of death and illness in the developed world and, once damaged, the heart has...
- IP3 Receptor Linked to Cardiac Hypertrophy Cardiac hypertrophy is a thickening of the heart muscle – characterized by increased cell size rather than number – in...
- Soluble Epoxide Hydrolase Inhibitors Cardiac hypertrophy, or thickening of the heart muscle, occurs naturally in athletes but may also be a pathological response to...
- Chymase Inhibitors Could Improve Outcomes for Heart Failure Patients Angiotensin converting enzyme (ACE) inhibitors are widely used for the treatment of hypertension and heart failure. The beneficial effects of...
- New Blood Pressure Target Although normally clinically silent, persistent hypertension and atherosclerosis are leading risk factors for strokes, heart attacks, heart failure, aneurysms and...
Related posts brought to you by Yet Another Related Posts Plugin.
This entry was posted on Wednesday, July 29th, 2009 at 8:30 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Entries (RSS)